Retailers Accelerate Hiring Amid Cautious Consumer Outlook Wall Street Remains Cautious on Snap Inc PostQ1 Results Amid Advertising Headwinds Bernstein Sees Up to 40 Upside Potential in Six Indian Pharma Stocks Oura Health Files Confidentially for IPO Signaling Potential Public Listing for Smart Ring Maker Chinas Worst Mining Disaster in Over a Decade Claims 82 Lives at Liushenyu Mine Implications for Coal Sector Safety Traders on Prediction Markets See Rising Odds of Federal Reserve Rate Hike by Mid2027 SNTI Q1 2026 Earnings NarrowerThanExpected Loss Cautiously Lifts Shares authID Inc AUID Q1 2026 Earnings Narrowing Losses as Biometric Platform Gains Traction VSTS Q1 2026 Earnings EPS Surges 89 Above Estimates Stock Gains Victory Capital Holdings Inc VCTR Q1 2026 Earnings EPS Tops Estimates as Asset Manager Delivers Solid Profit Performance ORGO Q1 2026 Earnings Significant EPS Miss Raises Concerns CMS Q1 2026 Earnings Slight EPS Beat Amid Steady Utility Operations MarisTech Ltd Warrants MTEKW Hold Steady at 016 Navigating Support and Resistance Levels OYSE Hovers Near Trust Value as Slight Dip Reflects Cautious Trading Fair Isaac FICO Rallies 171 as Stock Tests Key Resistance Levels SailPoint Inc SAIL Surges Over 4 as Shares Approach Resistance Level Globus Maritime GLBS Nears Support After 195 Decline Key Levels for Traders to Monitor Labor Market Cools but Remains Resilient What to Expect from April Jobs Report RCAT Q1 2026 Earnings Negative EPS Surprise as Strategic Initiatives Continue Travelers TRV Holds Steady Near Support as Market Awaits Catalysts FB Bancorp Inc FBLA Holds Steady at 1402 as Traders Await Catalyst Axogen Inc AXGN Shows Mild Pullback Near Resistance Consolidation Possible Rithm Acquisition Corp RAC Holds Steady at 1042 as SPAC Trading Remains Quiet Blackbaud BLKB Stock Bounces Testing Resistance Near 3147 After 118 Gain Crane Harbor Acquisition Corp II Rights CRANR Holds Steady at 022 as Trading Remains Muted Gores Holdings X GTEN Edges Higher Testing Resistance at 1088 After Modest Gain Alzamend Neuro ALZN Slides 174 as Stock Tests Key Support at 107